Jonathan Sackner‐Bernstein

4.4k total citations · 1 hit paper
45 papers, 3.2k citations indexed

About

Jonathan Sackner‐Bernstein is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Neurology. According to data from OpenAlex, Jonathan Sackner‐Bernstein has authored 45 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 3 papers in Neurology. Recurrent topics in Jonathan Sackner‐Bernstein's work include Heart Failure Treatment and Management (26 papers), Cardiac pacing and defibrillation studies (10 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Jonathan Sackner‐Bernstein is often cited by papers focused on Heart Failure Treatment and Management (26 papers), Cardiac pacing and defibrillation studies (10 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Jonathan Sackner‐Bernstein collaborates with scholars based in United States, United Kingdom and Netherlands. Jonathan Sackner‐Bernstein's co-authors include Keith D. Aaronson, Hal A. Skopicki, Marcin Kowalski, Marshal Fox, Milton Packer, Mary Ann Lukas, Wilson S. Colucci, Sarah Young, David Kanter and Sanjay Kaul and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Jonathan Sackner‐Bernstein

42 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure

2005 534 citations Jonathan Sackner‐Bernstein, Hal A. Skopicki et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Sackner‐Bernstein United States	17	2.6k	444	307	300	290	45	3.2k
Karl Swedberg Sweden	29	3.6k 1.4×	470 1.1×	332 1.1×	205 0.7×	617 2.1×	141	4.3k
Theophilus Owan United States	14	3.3k 1.3×	360 0.8×	222 0.7×	157 0.5×	447 1.5×	35	3.7k
Gordon W. Moe Canada	34	2.6k 1.0×	290 0.7×	606 2.0×	186 0.6×	350 1.2×	89	3.4k
J Korewicki Poland	17	2.9k 1.1×	344 0.8×	178 0.6×	223 0.7×	445 1.5×	67	3.4k
Charles Porter United States	18	2.2k 0.8×	256 0.6×	297 1.0×	270 0.9×	564 1.9×	38	3.1k
James C. Fang United States	27	2.1k 0.8×	315 0.7×	276 0.9×	297 1.0×	547 1.9×	69	3.0k
Maria Anastasiou‐Nana Greece	36	2.5k 1.0×	392 0.9×	272 0.9×	385 1.3×	679 2.3×	173	3.8k
A. Mosterd Netherlands	7	2.3k 0.9×	250 0.6×	196 0.6×	169 0.6×	313 1.1×	9	2.8k
Mihai Gheorghiade United States	22	1.9k 0.7×	578 1.3×	214 0.7×	177 0.6×	348 1.2×	43	2.6k
Guillermo Cintrón United States	13	2.8k 1.1×	368 0.8×	160 0.5×	229 0.8×	474 1.6×	27	3.3k

Countries citing papers authored by Jonathan Sackner‐Bernstein

Since Specialization

Citations

This map shows the geographic impact of Jonathan Sackner‐Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Sackner‐Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Sackner‐Bernstein more than expected).

Fields of papers citing papers by Jonathan Sackner‐Bernstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Sackner‐Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Sackner‐Bernstein. The network helps show where Jonathan Sackner‐Bernstein may publish in the future.

Co-authorship network of co-authors of Jonathan Sackner‐Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Sackner‐Bernstein. A scholar is included among the top collaborators of Jonathan Sackner‐Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Sackner‐Bernstein. Jonathan Sackner‐Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sackner‐Bernstein, Jonathan. (2024). Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?. Journal of Neurology. 271(8). 5687–5695. 2 indexed citations

Sackner‐Bernstein, Jonathan. (2021). Estimates of Intracellular Dopamine in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Journal of Parkinson s Disease. 11(3). 1011–1018. 10 indexed citations

Sackner‐Bernstein, Jonathan, David Kanter, & Sanjay Kaul. (2015). Dietary Intervention for Overweight and Obese Adults: Comparison of Low-Carbohydrate and Low-Fat Diets. A Meta-Analysis. PLoS ONE. 10(10). e0139817–e0139817. 157 indexed citations

O’Connor, Christopher M., Alan B. Miller, John E. Blair, et al.. (2010). Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program. American Heart Journal. 159(5). 841–849.e1. 193 indexed citations

Sackner‐Bernstein, Jonathan. (2009). Reducing the risks of sudden death and heart failure post myocardial infarction: Utility of optimized pharmacotherapy. Clinical Cardiology. 28(S1). 19–27. 3 indexed citations

Hauptman, Paul J., Susan J. Pressler, Jonathan Sackner‐Bernstein, Paul Ordronneau, & James E. Udelson. (2006). Rationale and Design of CASPER: Compliance and Quality of Life Study Comparing Once-Daily Carvedilol CR and Twice-Daily Carvedilol IR in Patients with Heart Failure. The American Journal of Cardiology. 98(7). 60–66. 11 indexed citations

Sackner‐Bernstein, Jonathan, Hal A. Skopicki, & Keith D. Aaronson. (2005). Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure. Circulation. 111(12). 1487–1491. 534 indexed citations breakdown →

Sackner‐Bernstein, Jonathan. (2005). Management of diuretic-refractory, volume-overloaded patients with acutely decompensated heart failure. Current Cardiology Reports. 7(3). 204–210. 9 indexed citations

Sackner‐Bernstein, Jonathan. (2004). Practical guidelines to optimize effectiveness of β-blockade in patients postinfarction and in those with chronic heart failure. The American Journal of Cardiology. 93(9). 69–73. 5 indexed citations

10.

Sackner‐Bernstein, Jonathan & Seth Godin. (2004). Increasing Organ Transplantation—Fairly. Transplantation. 77(1). 157–159. 6 indexed citations

11.

Behr, Thomas M., Robert N. Willette, Robert W. Coatney, et al.. (2004). Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease. Journal of Hypertension. 22(3). 583–592. 27 indexed citations

12.

Sackner‐Bernstein, Jonathan, Gwendolyn Niebler, & Craig Q. Earl. (2004). Cardiovascular Profile of Modafinil: Effects on Blood Pressure and Heart Rate. CHEST Journal. 126(4). 729S–729S. 2 indexed citations

13.

Fonarow, Gregg C., William T. Abraham, Christopher P. Cannon, et al.. (2003). Role of β-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction. The post-myocardial infarction guideline committee. Reviews in Cardiovascular Medicine. 4. 1 indexed citations

14.

DeRose, Joseph J., Robert C. Ashton, Scott Belsley, et al.. (2003). Robotically assisted left ventricular epicardial lead implantation for biventricular pacing. Journal of the American College of Cardiology. 41(8). 1414–1419. 79 indexed citations

15.

Maurer, Mathew S., Daniel Burkhoff, Donald L. King, et al.. (2003). Hemodynamic mechanisms of ejection fraction improvement with chronic carvedilol treatment in heart failure: Insights from three-dimensional echocardiography. Journal of the American College of Cardiology. 41(6). 218–219. 2 indexed citations

16.

Sackner‐Bernstein, Jonathan, Sanjay Arora, & Craig Q. Earl. (2003). Safety of the centrally acting wake-promoting agent modafinil in hypertensive sleep apnea patients. Journal of the American College of Cardiology. 41(6). 310–311. 1 indexed citations

17.

Sackner‐Bernstein, Jonathan, et al.. (2003). How should diuretic-refractory, volume-overloaded heart failure patients be managed?. PubMed. 15(10). 585–90. 3 indexed citations

18.

Sackner‐Bernstein, Jonathan, et al.. (1998). Evidence against heart rate reduction as the primary mechanism of action of carvedilol in chronic heart failure. Journal of the American College of Cardiology. 31. 32–32. 3 indexed citations

19.

Sackner‐Bernstein, Jonathan. (1998). Use of carvedilol in chronic heart failure: Challenges in therapeutic management. Progress in Cardiovascular Diseases. 41(1). 53–58. 14 indexed citations

20.

Packer, Milton, Wilson S. Colucci, Jonathan Sackner‐Bernstein, et al.. (1996). Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure. Circulation. 94(11). 2793–2799. 458 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact